Suchergebnisse - "Rahman, Omar"

PubPharm (59)

41

Everolimus-based combination for the treatment of advanced gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) : biological rationale and critical review of published data

enthalten in: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine | 2015

von Abdel-Rahman, O. | Fouad, M.

42

Risk of gastrointestinal complications in cancer patients treated with immune checkpoint inhibitors : a meta-analysis

enthalten in: Immunotherapy | 2015

von Abdel-Rahman, O. | ElHalawani, H. | Fouad, M.

43

Risk of mucocutaneous toxicities in patients with solid tumors treated with sunitinib : a critical review and meta analysis

enthalten in: Expert review of anticancer therapy | 2015

von Abdel-Rahman, O. | Fouad, M.

44

Risk of fatigue and hepatic and metabolic toxicities in patients with solid tumors treated with everolimus : a meta-analysis

enthalten in: Future oncology (London, England) | 2015

von Abdel-Rahman, O. | Fouad, M.

45

Risk of hematological toxicities in patients with solid tumors treated with ramucirumab : a meta-analysis

enthalten in: Future oncology (London, England) | 2015

von Abdel-Rahman, O. | ElHalawani, H.

46

Risk of selected gastrointestinal toxicities in cancer patients treated with MEK inhibitors : a comparative systematic review and meta-analysis

enthalten in: Expert review of gastroenterology & hepatology | 2015

von Abdel-Rahman, O. | ElHalawani, H. | Ahmed, H. | +1

47

Risk of oral and gastrointestinal mucosal injury in patients with solid tumors treated with everolimus, temsirolimus or ridaforolimus : a comparative systematic review and meta-analysis

enthalten in: Expert review of anticancer therapy | 2015

von Abdel-Rahman, O. | Fouad, M.

48

Risk of selected dermatological toxicities in cancer patients treated with MEK inhibitors : a comparative systematic review and meta-analysis

enthalten in: Future oncology (London, England) | 2015

von Abdel-Rahman, O. | ElHalawani, H. | Ahmed, H.

49

Risk of cutaneous toxicities in patients with solid tumors treated with immune checkpoint inhibitors : a meta-analysis

enthalten in: Future oncology (London, England) | 2015

von Abdel-Rahman, O. | ElHalawani, H. | Fouad, M.

50

Risk of fatal pulmonary events in patients with advanced non-small-cell lung cancer treated with EGF receptor tyrosine kinase inhibitors : a comparative meta-analysis

enthalten in: Future oncology (London, England) | 2015

von Abdel-Rahman, O. | Elhalawani, H.